CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
Fujian Superpipe
300198
WuHan Hvsen Biotechnology
300871
CN Stock MarketDetailed Quotes
300750 Contemporary Amperex Technology
- 256.92
- -2.56-0.99%
Post Market Mar 26 15:00 CST
1.13TMarket Cap22.29P/E (TTM)
262.70High256.70Low129.05KlotVolume259.40Open259.48Pre Close3.34BTurnover0.33%Turnover Ratio22.29P/E (Static)4.40BShares300.2752wk High4.58P/B1.00TFloat Cap165.5752wk Low311.38Limit Up3.90BShs Float376.43Historical High207.58Limit Down2.31%Amplitude8.41Historical Low2.01Dividend TTM258.52Avg Price60.89KlotAsk0.78%Div YieldTTM100Lot Size53.03KlotBid
Contemporary Amperex Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.70%362.01B | -12.09%259.04B | -11.88%166.77B | -10.41%79.77B | 22.01%400.92B | 40.10%294.68B | 67.52%189.25B | 82.91%89.04B | 152.07%328.59B | 186.72%210.34B |
| Operating revenue | -9.70%362.01B | -12.09%259.04B | -11.88%166.77B | -10.41%79.77B | 22.01%400.92B | 40.10%294.68B | 67.52%189.25B | 82.91%89.04B | 152.07%328.59B | 186.72%210.34B |
| Other operating revenue | 21.21%17.49B | ---- | 32.08%8.33B | ---- | -12.46%14.43B | ---- | -15.02%6.31B | ---- | 68.43%16.48B | ---- |
| Total operating cost | -13.49%303.3B | -17.56%215.47B | -14.71%142.3B | -12.24%69.62B | 19.36%350.61B | 36.65%261.38B | 60.85%166.85B | 68.31%79.33B | 163.76%293.75B | 206.22%191.28B |
| Operating cost | -15.58%273.52B | -19.15%186.03B | -17.39%122.52B | -16.27%58.7B | 23.63%323.98B | 34.97%230.1B | 61.42%148.31B | 68.40%70.1B | 172.70%262.05B | 220.58%170.48B |
| Operating tax surcharges | 21.35%2.06B | 40.94%1.56B | 52.42%973.68M | 109.09%574.39M | 86.84%1.7B | 94.24%1.11B | 96.05%638.81M | 73.55%274.71M | 86.52%907.48M | 70.66%568.94M |
| Operating expense | 17.09%3.56B | 6.90%10.93B | 4.56%7B | 16.13%3.39B | -72.59%3.04B | 45.55%10.22B | 93.21%6.7B | 90.19%2.92B | 154.11%11.1B | 167.24%7.02B |
| Administration expense | 14.51%9.69B | -2.07%6.77B | -2.68%4.39B | 24.42%2.3B | 21.25%8.46B | 54.71%6.92B | 70.26%4.51B | 48.57%1.85B | 107.15%6.98B | 100.79%4.47B |
| Financial expense | 16.15%-4.13B | -57.82%-2.89B | 62.54%-1.18B | 167.05%312.94M | -75.99%-4.93B | 0.44%-1.83B | -782.91%-3.16B | -124,666.61%-466.75M | -336.68%-2.8B | -269.60%-1.84B |
| -Interest expense (Financial expense) | 12.55%3.88B | 27.98%2.97B | 41.97%2.06B | 50.88%1.05B | 61.63%3.45B | 43.63%2.32B | 38.59%1.45B | 42.37%694.81M | 83.65%2.13B | 123.59%1.61B |
| -Interest Income (Financial expense) | -14.19%-9.5B | -25.38%-7.13B | -38.09%-5.01B | -52.71%-2.63B | -108.70%-8.32B | -118.44%-5.68B | -151.86%-3.63B | -160.59%-1.72B | -71.63%-3.99B | -66.08%-2.6B |
| Research and development | 1.37%18.61B | -12.12%13.07B | -12.77%8.59B | -6.71%4.34B | 18.35%18.36B | 40.65%14.88B | 70.77%9.85B | 81.16%4.65B | 101.66%15.51B | 130.18%10.58B |
| Credit Impairment Loss | -243.46%-872.53M | -258.98%-891.72M | -294.02%-429.76M | -171.11%-267.72M | 77.84%-254.04M | 51.79%-248.4M | 154.78%221.51M | 1,813.50%376.46M | -8,517.37%-1.15B | -468.94%-515.23M |
| Asset Impairment Loss | -43.89%-8.42B | -133.54%-6.65B | -0.53%-1.91B | 53.54%-507.56M | -107.08%-5.85B | -212.84%-2.85B | -641.75%-1.9B | -19,161.76%-1.09B | -38.95%-2.83B | 35.64%-910.44M |
| Adjustment items of total operating cost | 0.00%1K | -200.00%-100 | ---100 | ---- | --1K | 0.00%100 | ---- | --100 | ---- | --100 |
| Other net revenue | 56.60%5.34B | -31.41%2.55B | 71.84%5.08B | 37.77%3.18B | 72.87%3.41B | 9.53%3.72B | 21.31%2.96B | 153.34%2.31B | 136.30%1.97B | 56,006.58%3.4B |
| Fair value change income | 1,335.54%664.22M | -11.56%190.41M | -111.41%-24.33M | -165.06%-73.45M | -88.44%46.27M | -18.07%215.3M | -1.06%213.28M | --112.9M | --400.24M | --262.79M |
| Invest income | 25.04%3.99B | 42.81%3.13B | 46.50%2.08B | -46.47%817.64M | 26.83%3.19B | -20.22%2.19B | -21.00%1.42B | 231.40%1.53B | 103.99%2.51B | 2,145.69%2.74B |
| -Including: Investment income associates | -0.07%3.74B | 107.45%2.71B | 237.28%1.92B | 13.42%665.87M | 43.27%3.75B | -56.36%1.31B | -71.86%568.28M | 1.93%587.11M | 354.04%2.61B | 935.12%3B |
| Asset deal income | 13.75%19.32M | 262.62%47.59M | 32.65%11.05M | -76.86%3.69M | 419.09%16.98M | 1,247.82%13.12M | 6,108.23%8.33M | 85.66%15.94M | 77.05%-5.32M | -175.70%-1.14M |
| Other revenue | 59.04%9.97B | 52.99%6.73B | 78.71%5.36B | 134.54%3.21B | 106.34%6.27B | 142.17%4.4B | 175.35%3B | 198.82%1.37B | 81.50%3.04B | 58.64%1.82B |
| Adjusted Items effecting operating profit | --1K | --100 | ---- | ---100 | ---- | ---- | 0.00%100 | ---- | --100 | --100 |
| Operating profit | 19.24%64.05B | 24.61%46.13B | 16.55%29.55B | 10.95%13.33B | 45.89%53.72B | 64.82%37.02B | 117.04%25.36B | 389.25%12.02B | 85.75%36.82B | 106.20%22.46B |
| Add:Non operating Income | -73.11%135.42M | -65.80%142.6M | -71.65%85.08M | -84.73%26.66M | 215.93%503.68M | 262.50%416.99M | 276.90%300.14M | 327.16%174.63M | -12.90%159.43M | 66.92%115.03M |
| Less:Non operating expense | 226.44%1.01B | 105.93%547.87M | 0.64%189.7M | -11.48%159.19M | -0.20%307.92M | 7.90%266.04M | 256.09%188.48M | 979.12%179.82M | 157.90%308.55M | 183.98%246.56M |
| Add:Adjusted items effecting total profit | ---- | ---- | ---- | ---100 | ---- | 200.00%100 | ---- | ---- | ---100 | ---100 |
| Total profit | 17.19%63.18B | 23.02%45.72B | 15.63%29.45B | 9.90%13.2B | 47.01%53.91B | 66.46%37.17B | 117.50%25.47B | 384.27%12.01B | 84.40%36.67B | 105.33%22.33B |
| Less:Income tax cost | 28.27%9.18B | 50.26%6.99B | 14.40%4.57B | 3.82%2B | 122.44%7.15B | 72.55%4.65B | 95.89%4B | 282.43%1.93B | 58.69%3.22B | 55.89%2.69B |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | --100 | ---- | ---100 | ---- | ---- | ---- | ---- |
| Net profit | 15.50%54.01B | 19.12%38.73B | 15.86%24.88B | 11.06%11.2B | 39.76%46.76B | 65.63%32.52B | 122.06%21.47B | 410.29%10.08B | 87.32%33.46B | 114.68%19.63B |
| Net profit from continuing operation | 15.50%54.01B | 19.12%38.73B | 15.86%24.88B | 11.06%11.2B | 39.76%46.76B | 65.63%32.52B | 122.06%21.47B | 410.29%10.08B | 87.32%33.46B | 114.68%19.63B |
| Less:Minority Profit | 23.57%3.26B | 99.31%2.73B | 166.41%2.01B | 165.43%685.72M | -3.23%2.64B | -32.82%1.37B | -49.67%755.94M | -46.47%258.34M | 41.39%2.73B | 46.40%2.04B |
| Net profit of parent company owners | 15.01%50.74B | 15.59%36B | 10.37%22.86B | 7.00%10.51B | 43.58%44.12B | 77.05%31.15B | 153.64%20.72B | 557.97%9.82B | 92.89%30.73B | 126.95%17.59B |
| Add:Adjusted items effecting net profit of parent company owners | ---1K | ---- | ---- | ---- | ---- | ---100 | ---- | ---- | 0.00%-100 | ---- |
| Earning per share | ||||||||||
| Basic earning per share | 15.11%11.58 | 15.41%8.1894 | 10.20%5.2017 | 6.70%2.3909 | 40.18%10.06 | 70.97%7.0958 | 141.14%4.7201 | 247.99%2.2407 | 4.37%7.1766 | 24.02%4.1502 |
| Diluted earning per share | 15.22%11.58 | 15.51%8.1829 | 10.29%5.1975 | 6.93%2.389 | 40.46%10.05 | 71.59%7.0844 | 142.03%4.7125 | 248.82%2.2342 | 4.62%7.1553 | 23.90%4.1287 |
| Other composite income | 64.18%-1.69B | 80.80%-568.01M | -7.09%-1.94B | 92.13%-229.05M | -193.37%-4.71B | -176.74%-2.96B | -207.17%-1.81B | -86.35%-2.91B | 67.44%5.05B | 219.41%3.86B |
| Other composite income of parent company owners | 60.37%-1.8B | 74.96%-748.96M | -16.72%-2.09B | 86.40%-404.48M | -196.40%-4.55B | -182.68%-2.99B | -197.75%-1.79B | -223.89%-2.97B | 53.28%4.72B | 214.10%3.62B |
| Other composite income of minority owners | 173.51%116.67M | 460.56%180.96M | 1,033.67%154.87M | 185.82%175.43M | -149.06%-158.72M | -86.45%32.28M | 88.62%-16.59M | 109.52%61.38M | 580.45%323.53M | 329.78%238.31M |
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---100 | ---- | --100 | ---- | ---- | ---- | ---- |
| Total composite income | 24.42%52.32B | 29.12%38.17B | 16.67%22.94B | 52.98%10.97B | 9.21%42.05B | 25.84%29.56B | 73.14%19.66B | 1,635.97%7.17B | 84.45%38.5B | 126.89%23.49B |
| Total composite income of parent company owners | 23.69%48.94B | 25.21%35.25B | 9.77%20.77B | 47.54%10.11B | 11.61%39.57B | 32.75%28.15B | 89.23%18.93B | 1,091.44%6.85B | 86.47%35.45B | 138.23%21.21B |
| Total composite income of minority owners | 36.18%3.38B | 107.63%2.91B | 193.33%2.17B | 169.35%861.15M | -18.69%2.48B | -38.43%1.4B | -45.48%739.35M | 297.48%319.72M | 63.88%3.05B | 57.24%2.28B |
| Add:Adjusted items effecting total composite income | --1K | ---- | ---- | ---100 | ---- | 200.00%100 | ---- | ---- | ---- | 0.00%-100 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
